Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - CAPITAL EXPENDITURES
Capital Expenditures APLS - Apellis Pharmaceuticals, Inc.
-773 K
LAST VALUE
16.29%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR